Perlingeiro/Azzag Publish Review Article in Advanced Drug Delivery Reviews
In a comprehensive new review published in Advanced Drug Delivery Reviews, Lillehei Heart Institute professor Rita Perlingeiro, Ph.D., and researcher Karim Azzag, Ph.D., provide a roadmap for the future of treating skeletal muscle disorders.
The article, titled "Progress on cell therapy for skeletal muscle disorders," examines the evolution of regenerative medicine, focusing on the transition from traditional donor-derived cells to the groundbreaking potential of induced pluripotent stem cells (iPSCs). Skeletal muscle disorders, including various forms of muscular dystrophy, have long lacked curative treatments. Perlingeiro and Azzag detail how current advancements in cell engineering and delivery methods are overcoming historical hurdles like poor cell survival and limited distribution.
By synthesizing decades of research with the latest clinical breakthroughs, the authors highlight the critical role of the "niche" environment in ensuring successful muscle regeneration. This publication underscores the Perlingeiro lab's position at the forefront of genetic and cell-based therapies. The review offers a hopeful look at a new era of personalized medicine where lab-grown cells could one day restore strength and mobility to those living with debilitating muscle conditions.
